Skip to main content
Clinical Trials/IRCT2012091110817N1
IRCT2012091110817N1
Completed
未知

sing novel biomarkers for detection and comparison of nephrotoxicity induced by various doses of amikacin in geriatric critically ill patients: A randomized clinical trial

Tehran University of Medical Sciences0 sites40 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
sepsis.
Sponsor
Tehran University of Medical Sciences
Enrollment
40
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • age equal to or more than 65; serum creatinin equal to or less than 1\.2 or estimated GFR equal to or more than 40 ml/min; sepsis with gram negative or unknown microorganism in geriatric patients addmited in ICU and need for an aminoglycoside and no history of aminoglycoside administration in the last 30 days. Exclusion criteria: age less than 65; aminoglycoside administration in the last 30 days; BMI more than 35; Allergy to aminoglycosides; amikacin administration less than 5 days; trouph levels more than 10 mcg/ml; need for amikacin dose adjustment during study period; neoplasm diagnisis with chemotherapy or radiotherapy history; viral hepatitis; moderate to severe renal failure considering normal decline in GFR with aging ( Scr more than 1\.2\); life expectancey less than 48 hours and APACHE II score more than 35\.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials